公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues | Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Lin H.H.; Wang C.-C.; JIA-HORNG KAO | Hepatology Research | 2 | 0 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 9 | 6 | |
2009 | Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease | Wang C.-C.; Lin S.-K.; Tseng Y.-F.; Hsu C.-S.; TAI-CHUNG TSENG ; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 53 | 46 | |
2017 | Elimination of Hepatitis B: Is It a Mission Possible? | TAI-CHUNG TSENG ; JIA-HORNG KAO | BMC Medicine | 29 | 27 | |
2004 | End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B | CHUN-JEN LIU ; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | World Journal of Gastroenterology | 14 | 12 | |
2011 | Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease | Keating G.M.; Buti M.; Gadano A.; JIA-HORNG KAO ; Lee C.-M.; Peng C.-Y.; Schiff E.R.; Tanwandee T. | Drugs | 22 | 18 | |
2024 | Environment contamination and intra-hospital spread of COVID-19 in a tertiary care Hospital in Taiwan | SUNG-CHING PAN ; KUAN-YIN LIN ; Liu, Ying-Chieh; Wu, Chin-Ting; Ting, Ling; Ho, Shu-Yuan; YU-SHAN HUANG ; YEE-CHUN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2023 | Erratum to 'Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease' (JHEP Reports 5 [2023] 100836) | Cheng, Yu-Ming; Hsieh, Tsung-Han; Wang, Chia-Chi; JIA-HORNG KAO | JHEP reports : innovation in hepatology | 0 | | |
2008 | Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3) | Liaw Y.-F.; Leung N.; JIA-HORNG KAO ; Teerha P.; Gane E.; Han K.-H.; Guan R.; Lau G.K.K.; Locarnini S. | Hepatology International | 0 | 0 | |
2012 | Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 16 | 18 | |
2009 | Esomeprazole for asthma [7] | Hsu C.-S.; JIA-HORNG KAO | New England Journal of Medicine | 1 | 2 | |
2008 | Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis | CHEN-HUA LIU ; SHIH-JER HSU ; Liang C.-C.; FENG-CHIAO TSAI ; JOU-WEI LIN ; CHUN-JEN LIU ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN | Radiology | 27 | 24 | |
1995 | Evaluation of third-generation hepatitis C antibody assay in chronic hepatitis C and chronic non-B, non-C hepatitis | JIA-HORNG KAO ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Wang T.-H.; DING-SHINN CHEN | Viral Immunology | 3 | 2 | |
2023 | Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B | Lim, Young Suk; Kim, W. Ray; Dieterich, Douglas; JIA-HORNG KAO ; Flaherty, John F.; Yee, Leland J.; Roberts, Lewis R.; Razavi, Homie; Kennedy, Patrick T.F. | Viruses | 5 | 1 | |
2020 | Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals | CHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 42 | 43 | |
2021 | Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy | CHEN-HUA LIU ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Liu W.-C.; WANG-HUEI SHENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Journal of Viral Hepatitis | 6 | 6 | |
2007 | Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy | WANG-HUEI SHENG ; JIA-HORNG KAO ; PEI-JER CHEN ; LI-MIN HUANG ; SUI-YUAN CHANG ; HSIN-YUN SUN ; CHIEN-CHING HUNG ; Chen M.-Y.; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 72 | 66 | |
2006 | Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C | Chen B.-F.; CHUN-JEN LIU ; Jow G.-M.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of General Virology | 32 | 28 | |
2004 | Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 16 | 23 | |
2004 | Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Medical Virology | 24 | 21 | |